| Important: Hydroxycut Legal Actions Have Recently Been Registered |
| 06.15.09 | |
On May 1, 2009, there was a recall of 14 Hydroxycut diet-aid products coming from a number of reports that people using the products were developing significant liver problems and other health concerns. Less than seven days later, on May 4, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Settlements alleges company failure in informing the public about potential risks of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action court action is filed by a group of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there’s a settlement. At that time, the attorney who handled the suit will take his fees from the compensation that was given and then share the leftover funds to the litigants in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action suits became so popular.
The 1st class action lawsuit against Iovate was filed in Canada where the company is found and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall happened in the US where 23 cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained respiration, neurological, cardio, and gut issues as a consequence of Canadians using the products.
The Hydroxycut Settlement Suit alleges the company sold the products without correctly informing the general public of the health hazards that they could exposing patrons to. The complaint states the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled clients concerning the safety of the products.
